Researchers discover key to immune cell's 'internal guidance' system

February 5, 2012, University of British Columbia

University of British Columbia researchers have discovered the molecular pathway that enables receptors inside immune cells to find, and flag, fragments of pathogens trying to invade a host.

The discovery of the role played by the molecule CD74 could help immunologists investigate treatments that offer better immune responses against cancers, , and lead to more efficient vaccines.

The findings are published in this week's edition of .

"This could ultimately lead to a blueprint for improving the performance of a variety of vaccines, including those against HIV, tuberculosis and malaria," says UBC biologist Wilfred Jefferies, whose lab conducted the study. "This detailed understanding of the role of CD74 may also begin to explain differences in immune responses between individuals that could impact personalized medical options in the future."

CD74 is an important piece of inside dendritic cells – which regulate mammalian primary immune responses. possess specialized pathways that enable them to sense and then respond to foreign threats. Until now no one has been able to piece together the circuitry which enables a cellular receptor – Major Histocompatability Class I (MHC I) – inside the cells to find and 'collide' with foreign invaders.

The key finding of this work is the discovery of the guiding role played by CD74 to link MHC I receptors to compartments containing invading pathogens within the immune cell. This sophisticated circuit allows the immune cell to recognize and signal the presence of a pathogen in the body and to alert T immune fighter cells. The T-cells respond by dividing and attacking infected cells, destroying the pathogen.

Jefferies' team used 'knock-out' mice that had been genetically modified to lack the CD74 function to uncover the role of the molecule. The team--which includes research associate Genc Basha, postdoctoral fellow Anna Reinicke, graduate students Kyla Omilusik and Ana Chavez-Steenbock1, undergraduate student Nathan Lack, and technician Kyung Bok Choi –then confirmed their findings using biochemical analysis.

Explore further: T-cell discovery holds promise for organ transplant and immunodeficiency treatment

More information: The Nature Immunology study is available at: dx.doi.org/10.1038/ni.2225

Related Stories

T-cell discovery holds promise for organ transplant and immunodeficiency treatment

August 23, 2011
University of British Columbia researchers have solved a long-standing mystery surrounding the activation of T-cells, white blood cells that find and kill viruses and bacteria but also participate in the rejection of transplanted ...

Skin sentry cells promote distinct immune responses

July 21, 2011
A new study reveals that just as different soldiers in the field have different jobs, subsets of a type of immune cell that polices the barriers of the body can promote unique and opposite immune responses against the same ...

Recommended for you

Novel genomic tools provide new insight into human immune system

January 19, 2018
When the body is under attack from pathogens, the immune system marshals a diverse collection of immune cells to work together in a tightly orchestrated process and defend the host against the intruders. For many decades, ...

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

Researchers identify new way to unmask melanoma cells to the immune system

January 16, 2018
system, which enables these deadly skin cancers to grow and spread.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Cynical1
not rated yet Feb 06, 2012
Another important "bit" in the long "byte" of knowledge.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.